BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8645021)

  • 1. [Distributions of pyrimidine nucleoside phosphorylase (PyNPase) in tissues of benign and malignant mammary diseases--immunohistochemical observations].
    Fukada D; Saji S; Kawaguchi Y; Nagata M; Shimokawa K; Furuta T
    Gan To Kagaku Ryoho; 1996 May; 23(6):703-6. PubMed ID: 8645021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic effect of PyNPase (pyrimidine nucleoside phosphorylase) activity in breast cancer].
    Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Yamashita H; Fukuda M; Higuchi A; Masuyama S; Uchino S; Matsumoto H
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):59-66. PubMed ID: 9464330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of tissue PyNPase, TS, and DPD activities in breast cancer].
    Kosaka A; Mori K; Shikata A
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1395-401. PubMed ID: 12214467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs.
    Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Meyer C; Fukumoto M; Tobe T
    Anticancer Res; 1992; 12(4):1141-6. PubMed ID: 1386969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase levels to predict postoperative recurrence in primary breast cancer].
    Tamesa M; Yamamoto S; Maeda N; Nagashima Y; Oka M
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):431-6. PubMed ID: 18347391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase) and clinicopathological factors in patients with gastric cancer].
    Onoyama H; Urakawa T; Azumi Y; Hashimoto Y; Sugihara S; Saitoh Y
    Gan To Kagaku Ryoho; 2000 Jul; 27(7):1015-20. PubMed ID: 10925687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) in breast cancer].
    Seo S; Miki A; Iwaisako K; Kamo N; Inomoto T; Kitai T; Ukikusa M
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1579-82. PubMed ID: 17108722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in advanced gastric cancers].
    Tsukayama S; Hirano M; Murakami N; Uno Y; Nozawa H; Yoshino H; Orta N; Kikkawa H; Masuda S
    Gan To Kagaku Ryoho; 2001 May; 28(5):649-54. PubMed ID: 11383213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PyNPase and DPD expression potentially predict response to 5'-DFUR treatment for node-positive breast cancer patients].
    Akao S; Inoue K
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1361-4. PubMed ID: 14518422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between clinicopathological factors and the reduction of pyrimidine nucleoside phosphorylase activity after preoperative administration of 5'-deoxy-5-fluorouridine.
    Honda T; Inagawa H; Nishizawa T; Yoshimura H; Yamamoto I; Soma G
    Anticancer Res; 2010 Aug; 30(8):3207-11. PubMed ID: 20871042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/thymidine phosphorylase/platelet-derived endothelial cell growth factor and histological prognostic factor, and influence of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase activities and serum immunosuppressive acidic protein levels. A study group of oral anti-cancer drugs in Seiban/Tajima area].
    Satoh B; Ohtoshi M; Ishida Y; Hen-mi K; Kaneko I; Soda M; Sugihara J; Shibagaki F; Iwai N; Nakamura T; Yamasaki T; Matsumoto S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):359-64. PubMed ID: 9492829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/platelet-derived endothelial cell growth factor and histological prognostic factor, and influences of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase levels. 5'-DFUR Joint Research Group in the Osaka Area for Gastric Cancer].
    Yamasaki Y; Kuwata K; Hioki K; Sowa M; Hirakawa K; Okajima K; Isozaki H; Iwanaga T; Furukawa H; Nakano H; Watanabe A; Takami M; Tsukahara Y; Matsunaga S; Kikkawa N; Gotoh T; Tokuda H; Takahashi S; Toyohara M; Yagi M; Takebayashi J; Nakajima T; Miyazaki H; Kuwata H; Nakazato H
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1549-56. PubMed ID: 9725048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study of 5-FU levels and pyrimidine nucleoside phosphorylase (PyNPase) activity in human breast cancer tissue after administration of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Yayoi E; Takatsuka Y; Miyauchi K; Hirai T; Aikawa T; Maeura Y; Kaji M; Kitada M; Kotsuma Y; Satomi T
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1371-4. PubMed ID: 2142401
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antitumor effect of 5'-DFUR and PyNPase activity in colorectal cancer].
    Honda M; Tanaka Y; Matsuo Y; Yamamoto S; Hazama K; Inoue Y; Takao T; Fushimi H
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):939-43. PubMed ID: 10396321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5'DFUR) on breast cancer.
    Hata Y; Takahashi H; Sasaki F; Ogita M; Uchino J; Yoshimoto M; Akasaka Y; Nakanishi Y; Sawada Y
    Breast Cancer; 2000 Jan; 7(1):37-41. PubMed ID: 11029769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of preoperative oral 5'-DFUR on PyNPase level in gastrointestinal malignant tumor tissues].
    Wang WJ; Shi D; Wang SM
    Ai Zheng; 2003 Jun; 22(6):653-7. PubMed ID: 12948420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on pyrimidine nucleoside phosphorylase (PyNPase) activity in resected tissues of patients with gastric cancer].
    Ogawa K; Miura K; Katsube T; Wagatsuma Y; Konno S; Wakasugi S; Watanabe T; Shimakawa T; Ishikawa S; Naritaka Y
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1191-6. PubMed ID: 7661571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5-Fluorouracil level and pyrimidine nucleoside phosphorylase activity in cancer patients after oral administration of doxifluridine (5'-DFUR)].
    Maeda H; Miyamoto T; Mochinaga N; Tsunoda T
    Gan To Kagaku Ryoho; 1991 May; 18(6):965-9. PubMed ID: 1827573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of 5'-deoxy-5-fluorouridine (5'-DFUR) on the activity of pyrimidine nucleoside phosphorylase (pyNPase) in normal and tumor tissues of human stomach].
    Kimura T; Kobayashi T; Nakaya Y; Iida T; Uchimura M; Murohisa B; Nagashima T; Matsumoto Y; Kitamura H; Shibata M
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1051-6. PubMed ID: 7611757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5'-DFUR and lentinan on cytokines and PyNPase against AH66 ascites hepatoma in rats.
    Ogawa T; Ohwada S; Sato Y; Izumi M; Nakamura S; Takeyoshi I; Kawashima Y; Ohya T; Koyama T; Morishita Y
    Anticancer Res; 1999; 19(1A):375-9. PubMed ID: 10226570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.